Elevated Free T4 with Normal TSH and Fetal Goiter in Pregnancy
The most likely explanation is iatrogenic fetal hypothyroidism from maternal overtreatment with antithyroid drugs (ATDs), though you must also urgently rule out maternal Graves' disease with transplacental passage of TSH receptor antibodies (TRAb) causing fetal hyperthyroidism, or rare conditions like familial dysalbuminemic hyperthyroxinemia (FDH) or thyroid hormone resistance.
Primary Diagnostic Considerations
1. Iatrogenic Fetal Hypothyroidism (Most Common with Fetal Goiter)
Overtreatment of the mother with thioamides can result in iatrogenic fetal hypothyroidism 1. This scenario occurs when:
- The mother is receiving ATDs (propylthiouracil or methimazole)
- Maternal free T4 appears "normal" or elevated by standard immunoassay
- ATDs cross the placenta and suppress fetal thyroid function
- The fetus develops compensatory goiter from elevated fetal TSH
Critical pitfall: Free T4 immunoassays are unreliable in pregnancy due to increased thyroxine-binding globulin (TBG) and reduced albumin, which can artificially elevate or alter free T4 readings 1, 2. The "high" maternal free T4 may be an assay artifact while the mother is actually adequately treated or even hypothyroid, but the fetus is profoundly hypothyroid from transplacental ATD passage.
2. Fetal Hyperthyroidism from Maternal Graves' Disease
Fetal hyperthyroidism due to transplacental passage of maternal TRAb is rare (0.01% of pregnancies) but must be considered in any woman with past or current history of Graves' disease 1. Key features:
- Maternal TRAb levels usually exceed 3 times the upper normal limit (>5-6.8 IU/L) 1, 2
- Can occur even in mothers previously treated with radioiodine or thyroidectomy if TRAb persist
- Fetal goiter, tachycardia (>160 bpm), advanced bone age, growth restriction, or hydrops suggest fetal hyperthyroidism 1
- Maternal TSH may be normal if mother was previously ablated, but free T4 could be elevated from circulating TRAb stimulating remaining thyroid tissue
3. Assay Interference Syndromes
Familial dysalbuminemic hyperthyroxinemia (FDH) causes artifactually elevated free T4 on analog immunoassays while TSH remains normal 3. This benign condition:
- Shows increased albumin binding of T4 (but not T3)
- Free T4 estimate is falsely elevated by one-step analog assays
- Total T4 is elevated, but patient is clinically euthyroid
- Critical: Distinguishing this from true thyrotoxicosis is essential to avoid inappropriate treatment that could harm fetal development 3
Thyroid hormone resistance presents with elevated free T4 and free T3 with non-suppressed TSH 4. The only clinical manifestation may be goiter development during pregnancy, and treatment to normalize hormone levels is not required in asymptomatic patients 4.
Immediate Diagnostic Algorithm
Step 1: Obtain detailed maternal thyroid history
- Current or past Graves' disease (even if treated with radioiodine/surgery years ago)
- Current ATD use and dosing
- Family history of thyroid disorders or FDH
Step 2: Measure maternal TRAb immediately 1
- If TRAb >2-3× upper normal limit: suspect fetal hyperthyroidism
- If TRAb negative and on ATDs: suspect iatrogenic fetal hypothyroidism
- If TRAb negative and not on ATDs: consider assay interference (FDH, resistance)
Step 3: Verify free T4 measurement
- Request total T4 and calculate free T4 index, or use LC-MS/MS if available 1, 2
- Pregnancy-specific reference ranges must be applied (multiply non-pregnant range by 1.5 for 2nd/3rd trimester) 1
- Measure total T3 to assess T3/T4 ratio
Step 4: Detailed fetal ultrasound assessment 1 Evidence of fetal thyroid dysfunction includes:
- Thyroid enlargement/goiter (measure thyroid circumference)
- Fetal tachycardia (>160 bpm suggests hyperthyroidism)
- Growth restriction
- Polyhydramnios
- Advanced bone age
- Hydrops fetalis
Step 5: Consider cordocentesis only if diagnosis uncertain and would change management 1
- Fetal TSH, free T4, and TRAb from umbilical blood sampling
- Reserved for cases where clinical and sonographic data are inconclusive
Management Based on Diagnosis
If Iatrogenic Fetal Hypothyroidism (Mother on ATDs):
Immediately reduce maternal ATD dose 1. The goal is to maintain maternal free T4 at or just above the upper limit of normal for pregnancy to minimize fetal exposure while preventing maternal thyrotoxicosis 1.
- Monitor maternal thyroid function every 4-6 weeks
- Serial fetal ultrasounds every 4-6 weeks to assess goiter size
- If fetal hypothyroidism persists despite reduced maternal ATD, consider intra-amniotic levothyroxine injection after multidisciplinary discussion and confirmation by cordocentesis 1, 5
If Fetal Hyperthyroidism (Maternal TRAb Positive):
Treat with maternal ATDs (MMI or PTU) even if mother is euthyroid or hypothyroid 1. The ATDs cross the placenta to treat the fetus:
- Frequent clinical, laboratory, and ultrasound monitoring every 4-6 weeks 1
- Maternal free T4 and fetal assessment at 18-22 weeks and repeated regularly 1
- Balance maternal thyroid status (may need to add levothyroxine to mother if she becomes hypothyroid while treating fetal hyperthyroidism)
If Assay Interference (FDH or Resistance):
No treatment required 3, 4. These are benign conditions:
- Confirm diagnosis with total T4, T3, and appropriate assays
- Reassure patient and avoid unnecessary ATD treatment
- Monitor for goiter development (may be only clinical manifestation) 4
- Ensure neonatal thyroid function testing at delivery
Critical Monitoring Points
Neonatal assessment is mandatory 1, 2:
- TSH, free T4, and TRAb in umbilical cord blood if mother had TRAb or was on ATDs 1, 2
- Normal umbilical values do NOT exclude neonatal hyperthyroidism 2
- Repeat thyroid function at 3-5 days of life (rapid T4 increase beyond age-related upper limit predicts neonatal hyperthyroidism) 2
- Clinical signs appear later than biochemical abnormalities 2
The combination of elevated maternal free T4, normal TSH, and fetal goiter demands urgent investigation to prevent serious fetal/neonatal morbidity and mortality from untreated thyroid dysfunction.